Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.
Tani Y, Takita M, Wakui M, Saito H, Nishiuchi T, Zhao T, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Shinaha R, Tsubokura M. Tani Y, et al. Among authors: kodama t. Front Immunol. 2023 Aug 16;14:1240425. doi: 10.3389/fimmu.2023.1240425. eCollection 2023. Front Immunol. 2023. PMID: 37662950 Free PMC article.
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.
Kobashi Y, Kawamura T, Shimazu Y, Zhao T, Sugiyama A, Nakayama A, Kaneko Y, Nishikawa Y, Omata F, Takita M, Yamamoto C, Yoshida M, Kosaka M, Murayama A, Sugiura S, Tanaka M, Kawashima M, Uchi Y, Shindo J, Oikawa T, Shibuya K, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: kodama t. Sci Rep. 2022 Nov 7;12(1):18929. doi: 10.1038/s41598-022-21797-x. Sci Rep. 2022. PMID: 36344597 Free PMC article.
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.
Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Saito H, Yamamoto C, Zhao T, Takita M, Ito N, Tatsuno K, Kaneko Y, Nakayama A, Kodama T, Wakui M, Takahashi K, Tsubokura M. Yoshida M, et al. Among authors: kodama t. Sci Rep. 2023 Jun 7;13(1):9264. doi: 10.1038/s41598-023-36429-1. Sci Rep. 2023. PMID: 37286720 Free PMC article.
Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin.
Sakata J, Tatsumi T, Sugiyama A, Shimizu A, Inagaki Y, Katoh H, Yamashita T, Takahashi K, Aki S, Kaneko Y, Kawamura T, Miura M, Ishii M, Osawa T, Tanaka T, Ishikawa S, Tsukagoshi M, Chansler M, Kodama T, Kanai M, Tokuyama H, Yamatsugu K. Sakata J, et al. Among authors: kodama t. Protein Expr Purif. 2024 Feb;214:106375. doi: 10.1016/j.pep.2023.106375. Epub 2023 Oct 4. Protein Expr Purif. 2024. PMID: 37797818 Free article.
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays.
Saito H, Yoshimura H, Yoshida M, Tani Y, Kawashima M, Uchiyama T, Zhao T, Yamamoto C, Kobashi Y, Sawano T, Imoto S, Park H, Nakamura N, Iwami S, Kaneko Y, Nakayama A, Kodama T, Wakui M, Kawamura T, Tsubokura M. Saito H, et al. Among authors: kodama t. Vaccines (Basel). 2023 Nov 7;11(11):1694. doi: 10.3390/vaccines11111694. Vaccines (Basel). 2023. PMID: 38006026 Free PMC article.
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
Nakamura N, Kobashi Y, Kim KS, Park H, Tani Y, Shimazu Y, Zhao T, Nishikawa Y, Omata F, Kawashima M, Yoshida M, Abe T, Saito Y, Senoo Y, Nonaka S, Takita M, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Jeong YD, Tatematsu D, Akao M, Sato Y, Iwanami S, Fujita Y, Wakui M, Aihara K, Kodama T, Shibuya K, Iwami S, Tsubokura M. Nakamura N, et al. Among authors: kodama t. PLOS Digit Health. 2024 May 3;3(5):e0000497. doi: 10.1371/journal.pdig.0000497. eCollection 2024 May. PLOS Digit Health. 2024. PMID: 38701055 Free PMC article.
Group of longitudinal adverse event patterns after the fourth dose of COVID-19 vaccination with a latent class analysis.
Yamamoto C, Kobashi Y, Kawamura T, Nishikawa Y, Saito H, Oguro F, Zhao T, Takita M, Sawano T, Ozaki A, Abe T, Ito N, Kaneko Y, Nakayama A, Wakui M, Kodama T, Tsubokura M. Yamamoto C, et al. Among authors: kodama t. Front Public Health. 2024 Jul 30;12:1406315. doi: 10.3389/fpubh.2024.1406315. eCollection 2024. Front Public Health. 2024. PMID: 39139673 Free PMC article.
Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey.
Kobashi Y, Kawamura T, Shimazu Y, Kaneko Y, Nishikawa Y, Sugiyama A, Tani Y, Nakayama A, Yoshida M, Zho T, Yamamoto C, Saito H, Takita M, Wakui M, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: kodama t. Vaccine X. 2024 Sep 12;20:100553. doi: 10.1016/j.jvacx.2024.100553. eCollection 2024 Oct. Vaccine X. 2024. PMID: 39309610 Free PMC article.
Suv4-20h2 protects against influenza virus infection by suppression of chromatin loop formation.
Shiimori M, Ichida Y, Nukiwa R, Sakuma T, Abe H, Kajitani R, Fujino Y, Kikuchi A, Kawamura T, Kodama T, Toyooka S, Shirahige K, Schotta G, Kuba K, Itoh T, Imai Y. Shiimori M, et al. Among authors: kodama t. iScience. 2021 May 29;24(6):102660. doi: 10.1016/j.isci.2021.102660. eCollection 2021 Jun 25. iScience. 2021. PMID: 34169237 Free PMC article.
2,989 results